Deployable sensor platform on the lead system of an implantable device

Abstract
Systems and methods for deploying a sensor assembly onto a cardiac lead are disclosed. The sensor assembly can include a resilient cuff having one or more sensor modules for sensing physiological parameters within the body. The resilient cuff may have a substantially cylindrical shape having an inner diameter that is smaller than an outer diameter of the lead body onto which the cuff is deployed such that the cuff is retained on the lead body by frictional forces. The sensor assembly may be deployed in conjunction with a new lead to be implanted within a chamber of the patient's heart or a body vessel, or may be deployed onto an existing, implanted lead implanted within the patient's body.
Description
TECHNICAL FIELD

The present invention relates generally to implantable sensors. More specifically, the present invention relates to implantable sensors and systems and methods for deploying an implantable sensor at a location within a patient's heart or vasculature.


BACKGROUND

Implantable medical devices are often used to treat a variety of medical conditions. Examples of implantable medical devices include drug delivery devices, pain management devices, and devices that treat heart arrhythmias. One example of an implantable medical device used to treat heart arrhythmias is a cardiac pacemaker, which is commonly implanted in a patient to treat bradycardia (i.e., an abnormally slow heart rate). A pacemaker includes a pulse generator and one or more leads, which form electrical connection(s) between the pulse generator and the heart. An implantable cardioverter defibrillator (ICD) may be used to treat tachycardia (i.e., an abnormally rapid heart rate). An ICD also includes a pulse generator and leads that deliver electrical energy to the heart.


Implantable medical devices are also useful in the treatment of heart failure. For example, cardiac resynchronization therapy (CRT) (also commonly referred to as biventricular pacing) is an emerging treatment for heart failure, which involves stimulation of both the right and left ventricles to increase hemodynamic efficiency and cardiac output. In some cases, the treatment of heart failure and heart arrhythmias can be enhanced through the use of implanted sensors. In some systems, for example, a pressure sensor implanted within a chamber of the heart or in a body vessel such as an artery or vein can be used to sense blood pressure, which can be used to compute cardiac output, pulmonary vascular resistance, as well as other hemodynamic parameters. The sensor data from the sensor can be downloaded by a clinician and can be used to modify the therapy delivered by the implantable medical device.


SUMMARY

The present invention relates to implantable sensors and systems and methods for deploying an implantable sensor at a location within a patient's heart or vasculature.


In some embodiments, the present invention is a medical electrical lead. The medical electrical lead includes a lead body having a proximal section adapted to connect to a pulse generator, a distal section, and at least one electrical conductor extending within the lead body. At least one electrode is located on the lead body and is operatively coupled to the at least one electrical conductor. Additionally, the lead includes a resilient cuff frictionally engaged on an outer surface of the lead body; and at least one sensor coupled to the cuff and adapted to detect at least one physiological parameter.


In some embodiments, the present invention is a sensor assembly deployment system for deploying a sensor assembly onto a medical electrical lead. The system includes a delivery catheter having a lumen through which the medical electrical lead is adapted to be delivered. A sensor assembly is coupled to an outer surface of the delivery catheter and includes a resilient cuff and at least one sensor module adapted to detect a physiological parameter. A deployment member is slideably disposed over an outer surface of the delivery catheter and is located proximal to the sensor assembly. In certain embodiments, the deployment system includes an outer catheter having an interior lumen. The delivery catheter including the sensor assembly coupled thereto and deployment member are slideable within the interior lumen of the outer catheter.


In still some embodiments, the present invention is a method of coupling a sensor to an implantable medical electrical lead. An illustrative method includes providing a sensor assembly deployment system including: an outer catheter having an interior lumen; an inner catheter slideably disposed within the interior lumen of the outer catheter; a sensor assembly coupled to an outer surface of the inner catheter, the sensor assembly including a resilient cuff and at least one sensor module; and a deployment member located proximal to the sensor assembly. Additionally, the method includes delivering a medical electrical lead through the interior lumen of the inner catheter to a target location within the heart and securing the lead at the target location within. Next, the deployment member is advanced in a distal direction to deploy the sensor assembly from the inner catheter and onto an outer surface of the lead body. Upon deployment onto the lead body, the sensor assembly frictionally engages the outer surface of the lead body.


While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic view of a cardiac rhythm management system including a cardiac lead implanted within a patient's heart in accordance with an embodiment.



FIG. 2 is a schematic view of a portion of a cardiac lead including a sensor assembly deployed within a vessel according to an illustrative embodiment.



FIG. 3A is a perspective view of a sensor assembly according to an illustrative embodiment.



FIG. 3B is a perspective view of a sensor assembly according to another illustrative embodiment.



FIG. 4 is an end, cross-sectional view showing the sensor assembly of FIG. 3B coupled to a lead body according to an illustrative embodiment.



FIGS. 5A and 5B are schematic views of a lead and sensor assembly during delivery of the lead within a vessel according to an illustrative embodiment.



FIG. 5C is a schematic view of the lead and sensor assembly of FIGS. 5A and 5B subsequent to delivery of the sensor assembly over the lead.



FIG. 6 is a schematic view of a lead and sensor assembly deployed within a vessel according to another embodiment.



FIG. 7 is a schematic view of a lead and sensor assembly deployed within a vessel according to another embodiment.





While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.


DETAILED DESCRIPTION


FIG. 1 is a schematic view of a cardiac rhythm management system 2 including a pulse generator 4 coupled to a lead 8 including a lead body 10 having a proximal section 12 and a distal section 14 deployed within a patient's heart 16. The lead body 10 includes at least one electrical conductor 18 extending within the lead body 10 from the proximal section 12 to the distal section 14. At least one electrode 20 is located on the lead body 10 and is operatively connected to the at least one electrical conductor 18. The heart 16 includes a right atrium 22, a right ventricle 24, a left atrium 26, and a left ventricle 29. The lead 8 can be deployed in a heart chamber, a cardiac vessel, or at some other desired location in the body. In the embodiment illustrated in FIG. 1, the distal section 14 of the lead body 10 is transvenously guided through the right atrium 22, the coronary sinus ostium 28, and into a branch of the coronary sinus 31 or great cardiac vein 33. The illustrated position of the lead body 10 may be used for delivering pacing and/or defibrillation energy to the left side of the heart 16 for the therapeutic treatment of arrhythmias or other cardiac disorders. The position of the lead body 10 may also be used to sense electrical activity occurring within the left side of the heart 16.


According to some embodiments, and as shown in FIG. 1, the cardiac rhythm management system 2 includes a sensor assembly 40 provided on the lead body 10. In some embodiments, the sensor assembly 40 may be delivered and coupled to an existing, implanted lead 8 using a delivery system designed for this purpose. In other embodiments, the sensor assembly 40 is assembled onto the lead body 10 prior to delivery and implantation of the lead 8 within the patient's heart 16. The sensor assembly 40 is delivered along with the lead 8 to a target location within the patient's heart 16 or in a body vessel leading into or from the heart 16. After implantation of the lead 8 at the target location, the position of the sensor assembly 40 may be adjusted to a location that is adequate for detecting the physiological parameter to be monitored and for transmitting information to the pulse generator 4, another device implanted within the body, and/or an external device such as a hand-held monitoring device.


In some embodiments, the data from the sensor assembly 40 can be used to adjust the parameters of the therapy being delivered. For example, the sensor assembly 40 can communicate with the pulse generator 4 via a wired or wireless communication link. The pulse generator 4 is configured to store and/or process the information received from the sensor assembly 40. The data received by the pulse generator 4 can be used to adjust the therapy parameters according to a pre-determined therapy protocol. In some embodiments, the sensor assembly 40 may wirelessly transmit sensor data directly to an external device 42. The sensor data received by the external device 42 may be stored and/or downloaded by a physician and used to adjust the therapy as necessary according to the therapy protocol.



FIG. 2 is a schematic view showing the distal section 14 of the lead body 10 and sensor assembly 40 implanted at a target location located within a cardiac vessel 33. According to one embodiment, as shown in FIG. 2, the implantable sensor assembly 40 can be positioned at a variety of locations over the outer surface 43 of the lead body 10 during the implantation procedure. The implantable sensor assembly 40 includes a sensor platform 44 and a sensor module 48 coupled to the platform 44. In some embodiments, the sensor module 48 is electrically coupled to the pulse generator 4 via an electrical conductor 52 such as an insulated wire. The electrical conductor 52 can be configured to provide an electrical current to power the sensor module 48 as well as to provide a means to transmit and/or receive data back and forth between the sensor 48 and the pulse generator 4. In other embodiments, the sensor module 48 can be a wireless sensor module having a self-contained power supply, and may wirelessly transmit data to the pulse generator 4 and/or an external device.



FIGS. 3A and 3B are perspective views of the sensor assembly 40 showing the sensor platform 44 and the sensor module 48 in greater detail. FIG. 4 is an end, cross-sectional view showing the sensor platform 44 coupled to the lead body 10. In certain embodiments, and as best shown in FIG. 3A, the sensor platform 44 is a substantially cylindrical resilient cuff 54 having an interior section 55 adapted to frictionally receive a portion of the lead body 10. The lead body 10 is inserted within the interior section 55 of the cuff 54 during coupling of the sensor assembly 40 to the lead body 10. In some embodiments, the cuff 54 is delivered over the exterior of the lead body 10 until a desired location for sensing is reached. Once the desired location has been reached, as further discussed in reference to FIGS. 5A-5C, the cuff 54 is then deployed such that interior section 55 contacts and frictionally engages the exterior of the lead body. According to various embodiments, the inner diameter of the cuff 54 is smaller than an outer diameter of the lead body 10 onto which the sensor assembly 40 is deployed such that the interior section 55 of the cuff 54 frictionally engages the lead body and the sensor assembly 40 is retained in position on the lead body 10 by frictional forces.


In some embodiments, as shown in FIG. 3B, the cylindrical cuff 54 includes a slit 56 extending from a first end 58 to a second end 60 of the cuff 54, which exposes a portion of the cuff 54 to permit the lead body 10 to be inserted within the interior section 55 during coupling of the sensor assembly 40 to the lead body 10. In some embodiments, the width W of the slit 56 is capable of expanding to receive the lead body 10 within the cuff 54 when the sensor assembly 40 is engaged onto the lead body 10. For example, in one embodiment, the width W of the slit 56 is smaller than an outer diameter or width of the lead body 10 and is adapted to expand to a size sufficient to permit the lead body 10 to be inserted into the interior section 55 of the cuff 54.


The cuff 54 can be made of a resilient, pliable material to facilitate insertion of the sensor assembly 40 over the lead body 10 during delivery. Exemplary materials include biocompatible materials such as silicone rubber and polyurethane. In certain embodiments, the cuff 54 may be made of a shape memory alloy or a shape memory polymer. Using a shape memory material such as, for example, Nitinol, allows the cuff 54 to be expanded to permit insertion of a lead body 10 into the interior section of the cuff 54 without permanent deformation of the cuff 54.


According to various embodiments, and as further shown in FIGS. 3A, 3B and 4, the sensor assembly 40 includes at least one sensor module 48. The sensor assembly 40 can include a single sensor module 48 or multiple sensor modules 48. In some embodiments, the sensor assembly 40 can include a first sensor module configured to detect a first physiological parameter and a second sensor module configured to detect a second physiological parameter. Multiple sensor modules configured to detect the same physiological parameter may also be employed. In certain embodiments, the sensor module(s) 48 is/are coupled to an outer surface 62 of the cuff 54. In other embodiments the sensor modules 48 can be embedded into the cuff 54 or mounted to the interior section 55 of the cuff 54. The sensor module 48 can include an electrical conductor that connects to the pulse generator 4, as discussed above in reference to FIG. 2, or can be a wireless sensor module 48.


The sensor module 48 can be configured to detect a variety of physiological parameters. For example, the sensor module 48 can be configured for sensing blood pressure, temperature, blood gas content, strain, fluid flow, chemical properties, electrical properties, magnetic properties, as well as various other physiological parameters. The sensor module 48 can be configured to interact with the implanted pulse generator 4 and transmit data indicative of the physiological parameter being monitored. In some embodiments, the data may be transmitted via the electrical conductor 52 (FIG. 2) to the pulse generator 4, where it may be processed and/or stored until it is accessed by a physician or other caregiver. In other embodiments, the sensor module 48 can be configured to wirelessly transmit the data to the pulse generator 4, to another implanted device, and/or to an external device such as an external computer or hand-held device. In some embodiments, for example, the sensor module 48 can be configured to acoustically transmit data to an external device in a manner described, for example, in U.S. patent application Ser. No. 11/373,005, now U.S. Pat. No. 8,078,278, entitled “Body Attachable Unit In Wireless Communication With Implantable Devices,” which is expressly incorporated herein by reference in its entirety for all purposes. Other telemetry modes such as radiofrequency or inductive communication can also be employed for wirelessly communicating with the pulse generator 4, another implanted device, and/or an external device. In some embodiments, the data transmitted by the sensor module 48 can be used to make adjustments to the therapy being delivered. For example, data indicative of the blood pressure in a chamber of the heart 16 can be used to provide closed-loop adjustment of pacing pulses delivered by the pulse generator 4 via the lead 8.



FIG. 5A is a schematic view of the distal section 14 of the lead body 10 and the sensor assembly 40 during delivery of the lead 8 to a target location within a vessel 33 and prior to deployment of the sensor assembly 40 onto the lead body 10. FIG. 5B is as schematic view of the distal section 14 of the lead body during deployment of the sensor assembly 40 onto the lead body. FIG. 5C is a schematic view of the distal section 14 of the lead body 10 after deployment of the sensor assembly 40 onto the lead body 10.


According to various embodiments, and as shown in FIGS. 5A-5C, a sensor assembly delivery system 70 is used to couple the sensor assembly 40 including the sensor platform 44 and the sensor module 48 (best shown in FIG. 5C) onto an outer surface 74 of the lead body 10 at a desired location. In certain embodiments, as shown in FIGS. 5A-5C, the sensor assembly delivery system 70 includes an inner catheter 78 slideably disposed within an outer catheter 82. In other embodiments, the inner catheter 78 is utilized during delivery without an outer catheter 82.


The inner catheter 78 includes a lumen 86 though which the lead body 10 can be delivered. Prior to deployment onto the lead body 10, and as shown in FIG. 5A, the sensor assembly 40 is retained on the inner catheter 78 by frictional forces. A deployment member 90, such as a pusher tube or hypotube, may be provided over the inner catheter 78 and is positioned proximal to the sensor assembly 40 to be deployed. In one embodiment, once the lead 8 has been delivered to the target location within the vessel 33, the inner catheter 78 can be moved in either a proximal or distal direction relative to the outer catheter 82 in order to position the sensor assembly 40 at a desired location for sensing. In certain embodiments, the inner catheter 78 may also be rotated to adjust the radial positioning of the sensor assembly 40 prior to deployment. Once the desired location for sensing has been selected, the deployment member 90 can be used to push the sensor assembly 40 in a distal direction off of the inner catheter 78 and onto the lead body 10, as shown in FIG. 5B. In other embodiments, the deployment member 90 can be used to hold the sensor assembly 40 stationary, and the inner catheter 78 is retracted proximally to engage the sensor assembly 40 onto the lead body 10.



FIG. 6 is a schematic view of a portion 70 of a newly implanted lead body 10 deployed within a vessel 33 according to another embodiment. As shown in FIG. 6, a sensor assembly 140 is provided over the outer surface 62 of the newly implanted lead body 10. In the illustrated embodiment, the sensor assembly 140 includes a sensor platform 144 and at least one sensor module 148 coupled to an outer surface 152 of the sensor platform 144. In the illustrated embodiment, the sensor platform 144 is configured to radially expand upon deployment from within the interior of a delivery catheter 154. In some embodiments, and as shown in FIG. 6, the sensor platform 144 may have a stent-like or basket configuration. In other embodiments, the sensor platform 144 may have a coiled configuration or other shape useful for supporting the sensor module 148. During delivery, the sensor assembly 140 is provided over the lead body 10 and is retained in a collapsed configuration by the delivery catheter until deployment. The delivery catheter 154 can be used to advance the lead body 140 to a desired location within the body for implantation. Additionally, the delivery catheter 154 can be used to adjust the position of the sensor assembly 140 at a desired location over the lead body 10. The delivery catheter 154 can be used to adjust the longitudinal position of the sensor assembly 140 over the lead body 10. Additionally, the delivery catheter 154 also may be used to rotate the position of the sensor assembly 140 over the lead body 10. In some embodiments, the delivery catheter 154 can be moved in a proximal direction relative to the lead body 10 to transition the sensor assembly 140 from a collapsed configuration to an expanded configuration. In other embodiments, the sensor assembly 140 may be secured in place on the outer surface 62 of the lead body 10, and the lead body 10 can be moved in a distal direction relative to the catheter 154 to expand the sensor assembly 140.


Unlike stent-like or basket-like fixation devices, the sensor platform 144 illustrated in FIG. 6 does not bear against the vessel walls 158 with a radial expansion force. Rather, the stent-like sensor platform 144 is made from a shape memory material and is configured to expand to an outer diameter that is less than the inner diameter of the vessel 33 so that the sensor module 148 is offset a distance from the vessel wall 158. A number of tether(s) 160 attached to the sensor platform 144 can be used to position the sensor platform 144 at a desired location over the outer surface 62 of the lead body 10. After positioning of the sensor platform 144, the sensor platform 144 is secured in place over the outer surface 62 of the lead body 10 by securing the tethers 160 to the proximal section 12 of the lead body 10. With the tether(s) 160 secured to the proximal section 12 of the lead body 10, the sensor platform 144 can be retained in place at a desired location on the lead body 10. In some embodiments, the tether(s) 160 may also be used as an electrical conduit for providing power to the sensor module 148 and for transmitting data signals back and forth between the sensor module 148 and the pulse generator 4. According to other embodiments, the stent-like sensor platform 144 may be retained in place on the lead body 10 by one or more stop features provided on the lead body 10, as more fully described in U.S. application Ser. No. 11/114,730, now U.S. Pat. No. 7,477,946, entitled “Fixation Device for Coronary Venous Lead,” which is expressly incorporated herein by reference in its entirety for all purposes.



FIG. 7 is a schematic view of a distal section 14 of a newly implanted lead body 10 and sensor assembly 244 deployed within a vessel 33 according to another embodiment. As shown in FIG. 7, a sensor assembly 244 includes an eyelet or loop 246 coupled to the lead body 10, which in some embodiments, may further serve as a guidewire management feature. A guidewire management feature facilitates and guides the insertion of a guidewire used during the implant procedure to traverse the body. In other embodiments, the sensor assembly 244 can be configured as a collar which encompasses the circumference of the lead body 10.


As shown in FIG. 7, the sensor module 248 is attached to a tether 252 which can be pre-threaded through the eyelet or loop 246 of the sensor assembly 244 prior to delivery of the lead body 10 within the patient's heart. In some embodiments, the tether 252 may comprise an insulated wire which, in addition to facilitating the delivery of the sensor module 248 onto the lead body 10, can be used to provide power to the sensor assembly 244 and to transmit data back and forth from the sensor module 248 to the pulse generator 4. In one embodiment, and as further shown in FIG. 7, the tether 252 can be configured with a slip-knot like feature 256 that can be secured to the eyelet or loop 246 using tension once the sensor module 248 has been delivered to a desired location along the length of the lead body 10. The tether 252 can be fabricated from suture string or thin, biocompatible wire. In some embodiments, the tether 252 can be the sensor lead used to transmit power to the sensor and convey data back and forth to and from the sensor module 248 and the pulse generator 4.


The lead body 10 can be delivered to the target location within the patient's heart using a stylet, catheter, or other suitable delivery device. Once the lead body 10 has been implanted at the target location within the patient's heart or in a body vessel leading to or from the heart, the position of the sensor module 248 can be adjusted by pulling on one end of the tether 252. Once a desired position for the sensor module has been identified, the tether 252 can be secured at the proximal end 12 of the lead body 10.


In certain embodiments, a sensor assembly such as described above according to the various embodiments can also be deployed onto an existing, implanted lead. For example, in one embodiment, a method of deploying a sensor assembly onto an existing implanted lead includes guiding a sensor deployment system to a location adjacent the existing implanted lead located within a patient's heart, engaging the lead body, and deploying a sensor assembly including at least a sensor module onto the lead body.


Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.

Claims
  • 1. A medical electrical lead configured for deployment within a vessel of a cardiovascular system, comprising: a lead body having a proximal section and a distal section, the proximal section of the lead body adapted to connect to a pulse generator;at least one electrical conductor extending within the lead body;at least one electrode located on the lead body and operatively coupled to the at least one electrical conductor;a resilient cuff sized and configured for frictional engagement with an outer surface of the lead body, the resilient cuff adapted to be disposed circumferentially about the lead body when the lead and the resilient cuff are deployed within the vessel; andat least one sensor module coupled to the cuff such that the sensor module is disposed in the vessel when the lead is disposed in the vessel, the at least one sensor module including a sensor adapted to detect at least one physiological parameter from within the vessel.
  • 2. The lead according to claim 1, wherein the sensor module further comprises an electrical conductor adapted to connect to the pulse generator.
  • 3. The lead according to claim 1, wherein the sensor is a wireless sensor and is adapted to communicate wirelessly to an external device.
  • 4. The lead according to claim 1, wherein the sensor is a wireless sensor and is adapted to communicate wirelessly with a pulse generator.
  • 5. The lead according to claim 1, wherein the at least one physiological parameter is selected from the group of parameters including blood pressure, temperature, blood gas content, strain, or fluid flow.
  • 6. The lead according to claim 1, wherein the at least one physiological parameter includes blood pressure.
  • 7. The lead according to claim 1, wherein the sensor module comprises a first sensor adapted to detect a first physiological parameter and a second sensor adapted to detect a second physiological parameter.
  • 8. The lead according to claim 1, wherein the cuff includes a slit extending from a first end of the cuff to a second end of the cuff, the slit comprising a width W smaller than an outer diameter of the lead body, the slit configured to expand such that the cuff width increases to a size sufficient to receive the lead body within an interior section of the cuff.
  • 9. The lead according to claim 1, wherein an inner diameter of the cuff is smaller than an outer diameter of the lead body.
  • 10. The lead according to claim 1, wherein the cuff comprises a shape memory material.
  • 11. A medical electrical lead configured for deployment within a cardiac vessel, comprising: a lead body having a proximal section and a distal section, the proximal section of the lead body adapted to connect to a pulse generator;at least one electrical conductor extending within the lead body;at least one electrode located on the lead body and operatively coupled to the at least one electrical conductor;a resilient cuff configured for frictional engagement with the outer surface of the lead body, the resilient cuff adapted to be disposed circumferentially about the lead body when the lead and the resilient cuff are deployed within the cardiac vessel; andat least one sensor module coupled to the cuff such that the sensor module is disposed in the vessel when the lead is disposed in the vessel, the at least one sensor module including a sensor adapted to detect at least one physiological parameter from within the vessel;wherein the sensor is a wireless sensor and is adapted to communicate wirelessly to an external device.
  • 12. The lead according to claim 11, wherein the wireless sensor is further adapted to communicate wirelessly with a pulse generator.
  • 13. The lead according to claim 11, wherein the at least one physiological parameter is selected from the group of parameters including blood pressure, temperature, blood gas content, strain, or fluid flow.
  • 14. The lead according to claim 13, wherein the at least one physiological parameter includes blood pressure.
  • 15. The lead according to claim 11, wherein the sensor module comprises a first sensor adapted to detect a first physiological parameter and a second sensor adapted to detect a second physiological parameter.
  • 16. The lead according to claim 11, wherein the cuff includes a slit extending from a first end of the cuff to a second end of the cuff, the slit comprising a width W smaller than an outer diameter of the lead body, the slit configured to expand such that the cuff width increases to a size sufficient to receive the lead body within an interior section of the cuff.
  • 17. The lead according to claim 11, wherein an inner diameter of the cuff is smaller than an outer diameter of the lead body.
  • 18. The lead according to claim 11, wherein the cuff comprises a shape memory material.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims the benefit under 35 U.S.C. §119 of U.S. Provisional Application No. 61/152,486, filed on Feb. 13, 2009, entitled “DEPLOYABLE SENSOR PLATFORM ON THE LEAD SYSTEM OF AN IMPLANTABLE DEVICE,” which is herein incorporated by reference in its entirety.

US Referenced Citations (212)
Number Name Date Kind
3874388 King et al. Apr 1975 A
4391124 Drost et al. Jul 1983 A
4407296 Anderson Oct 1983 A
4485813 Anderson et al. Dec 1984 A
4492107 Sandhu Jan 1985 A
4672976 Kroll Jun 1987 A
4836204 Landymore et al. Jun 1989 A
4846191 Brockway et al. Jul 1989 A
4900303 Lemelson Feb 1990 A
4917089 Sideris Apr 1990 A
4966148 Millar Oct 1990 A
5040538 Mortazavi Aug 1991 A
5218965 Ring Jun 1993 A
5284138 Kujawski Feb 1994 A
5303207 Brady et al. Apr 1994 A
5334217 Das Aug 1994 A
5411551 Winston et al. May 1995 A
5415630 Gory et al. May 1995 A
5451235 Lock et al. Sep 1995 A
5604531 Iddan et al. Feb 1997 A
5634936 Linden et al. Jun 1997 A
5656036 Palmaz Aug 1997 A
5662711 Douglas Sep 1997 A
5704352 Tremblay et al. Jan 1998 A
5725552 Kotula et al. Mar 1998 A
5733313 Barreras, Sr. et al. Mar 1998 A
5772669 Vrba Jun 1998 A
5775331 Raymond et al. Jul 1998 A
5800497 Bakels et al. Sep 1998 A
5824053 Khosravi et al. Oct 1998 A
5833603 Kovacs et al. Nov 1998 A
5855563 Kaplan et al. Jan 1999 A
5860923 Lenker et al. Jan 1999 A
5891154 Loeffler Apr 1999 A
5967980 Ferre et al. Oct 1999 A
5967986 Cimochowski et al. Oct 1999 A
5967989 Cimochowski et al. Oct 1999 A
5995876 Kruse et al. Nov 1999 A
6002969 Machek et al. Dec 1999 A
6015386 Kensey et al. Jan 2000 A
6015387 Schwartz et al. Jan 2000 A
6030413 Lazarus Feb 2000 A
6033366 Brockway et al. Mar 2000 A
6053873 Govari et al. Apr 2000 A
6076016 Feierbach Jun 2000 A
6077227 Miesel et al. Jun 2000 A
6097984 Douglas Aug 2000 A
6106464 Bass et al. Aug 2000 A
6140740 Porat et al. Oct 2000 A
6159156 Van Bockel Dec 2000 A
6179858 Squire et al. Jan 2001 B1
6193745 Fogarty et al. Feb 2001 B1
6214025 Thistle et al. Apr 2001 B1
6231516 Keilman May 2001 B1
6236889 Soykan et al. May 2001 B1
6239724 Doron et al. May 2001 B1
6240312 Alfano et al. May 2001 B1
6246898 Vesely et al. Jun 2001 B1
6277078 Porat et al. Aug 2001 B1
6278790 Davis et al. Aug 2001 B1
6309350 VanTassel Oct 2001 B1
6328699 Eigler et al. Dec 2001 B1
6331163 Kaplan Dec 2001 B1
6379308 Brockway et al. Apr 2002 B1
6409674 Brockway et al. Jun 2002 B1
6416474 Penner et al. Jul 2002 B1
6432050 Porat et al. Aug 2002 B1
6442413 Silver Aug 2002 B1
6447522 Gambale et al. Sep 2002 B2
6475170 Doron et al. Nov 2002 B1
6486588 Doron et al. Nov 2002 B2
6527780 Wallace et al. Mar 2003 B1
6543272 Vitek Apr 2003 B1
6585763 Keilman et al. Jul 2003 B1
6592553 Zhang et al. Jul 2003 B2
6628989 Penner et al. Sep 2003 B1
6645143 VanTassel et al. Nov 2003 B2
6660021 Palmer et al. Dec 2003 B1
6685638 Taylor et al. Feb 2004 B1
6689056 Kilcoyne et al. Feb 2004 B1
6699186 Wolinsky et al. Mar 2004 B1
6702847 DiCarlo Mar 2004 B2
6730108 Van Tassel et al. May 2004 B2
6738671 Christophersom et al. May 2004 B2
6743173 Penner et al. Jun 2004 B2
6746404 Schwartz Jun 2004 B2
6747916 Fleury et al. Jun 2004 B1
6755855 Yurek et al. Jun 2004 B2
6764446 Wolinsky et al. Jul 2004 B2
6783499 Schwartz Aug 2004 B2
6800060 Marshall Oct 2004 B2
6840956 Wolinsky et al. Jan 2005 B1
6855115 Fonseca et al. Feb 2005 B2
6868288 Thompson Mar 2005 B2
6890303 Fitz May 2005 B2
6899729 Cox May 2005 B1
6904308 Frisch et al. Jun 2005 B2
6920347 Simon et al. Jul 2005 B2
6926670 Rich Aug 2005 B2
6934573 Glukhovsky et al. Aug 2005 B1
6950690 Meron et al. Sep 2005 B1
6958034 Iddan Oct 2005 B2
6970742 Mann et al. Nov 2005 B2
6972017 Smith et al. Dec 2005 B2
6984205 Gazdzinski Jan 2006 B2
7001329 Kobayashi et al. Feb 2006 B2
7006858 Silver et al. Feb 2006 B2
7009634 Iddan et al. Mar 2006 B2
7011671 Welch Mar 2006 B2
7024248 Penner et al. Apr 2006 B2
7033322 Silver Apr 2006 B2
7035684 Lee Apr 2006 B2
7039453 Mullick et al. May 2006 B2
7060038 Letort et al. Jun 2006 B2
7064472 Peline et al. Jun 2006 B2
7065409 Mazar Jun 2006 B2
7076305 Imran et al. Jul 2006 B2
7083822 Brightbill Aug 2006 B2
7116352 Yaron Oct 2006 B2
7118529 Glukhovsky et al. Oct 2006 B2
7118531 Krill Oct 2006 B2
7131986 Sirhan et al. Nov 2006 B2
7160258 Imran et al. Jan 2007 B2
7181261 Silver et al. Feb 2007 B2
7198603 Penner et al. Apr 2007 B2
7211045 Dala-Krishna et al. May 2007 B2
7273457 Penner Sep 2007 B2
7283874 Penner Oct 2007 B2
7308319 Lovett et al. Dec 2007 B2
7338512 McGuckin, Jr. et al. Mar 2008 B2
7347868 Burnett et al. Mar 2008 B2
7392094 Zhang et al. Jun 2008 B2
7437193 Parramon et al. Oct 2008 B2
7452334 Gianchandani et al. Nov 2008 B2
7477946 Tockman et al. Jan 2009 B2
7555351 Zhang et al. Jun 2009 B2
7572228 Wolinsky et al. Aug 2009 B2
7744542 Piaget et al. Jun 2010 B2
7780694 Palmer et al. Aug 2010 B2
7801626 Moser Sep 2010 B2
7850708 Pal Dec 2010 B2
7890188 Zhang et al. Feb 2011 B2
20020045920 Thompson Apr 2002 A1
20020123672 Christophersom et al. Sep 2002 A1
20020165601 Clerc Nov 2002 A1
20020183628 Reich et al. Dec 2002 A1
20020188207 Richter Dec 2002 A1
20030114897 Von Arx et al. Jun 2003 A1
20030139796 Sequin et al. Jul 2003 A1
20030200031 de Kok Oct 2003 A1
20040006377 Behm Jan 2004 A1
20040116992 Wardle et al. Jun 2004 A1
20040147969 Mann et al. Jul 2004 A1
20040176672 Silver et al. Sep 2004 A1
20040204744 Penner et al. Oct 2004 A1
20040215228 Simpson et al. Oct 2004 A1
20050080472 Atkinson et al. Apr 2005 A1
20050096702 Denker et al. May 2005 A1
20050115561 Stahmann et al. Jun 2005 A1
20050124875 Kawano et al. Jun 2005 A1
20050136385 Mann et al. Jun 2005 A1
20050149108 Cox Jul 2005 A1
20050149128 Heil, Jr. et al. Jul 2005 A1
20050149155 Scheiner et al. Jul 2005 A1
20050149156 Libbus et al. Jul 2005 A1
20050165456 Mann et al. Jul 2005 A1
20050209678 Henkes et al. Sep 2005 A1
20050245840 Christopherson et al. Nov 2005 A1
20060009818 Von Arx et al. Jan 2006 A1
20060047205 Ludomirsky et al. Mar 2006 A1
20060064133 Von Arx et al. Mar 2006 A1
20060064134 Mazar et al. Mar 2006 A1
20060064142 Chavan et al. Mar 2006 A1
20060064143 Von Arx et al. Mar 2006 A1
20060079740 Silver et al. Apr 2006 A1
20060089627 Burnett et al. Apr 2006 A1
20060089694 Zhang et al. Apr 2006 A1
20060122522 Chavan et al. Jun 2006 A1
20060136004 Cowan et al. Jun 2006 A1
20060142819 Penner et al. Jun 2006 A1
20060149329 Penner Jul 2006 A1
20060149330 Mann et al. Jul 2006 A1
20060178586 Dobak, III Aug 2006 A1
20060206153 Libbus et al. Sep 2006 A1
20060241735 Tockman et al. Oct 2006 A1
20060259085 Zhang et al. Nov 2006 A1
20060287700 White et al. Dec 2006 A1
20060293741 Johnson et al. Dec 2006 A1
20070049833 Tearney et al. Mar 2007 A1
20070129637 Wolinsky et al. Jun 2007 A1
20070156126 Flaherty Jul 2007 A1
20070156205 Larson et al. Jul 2007 A1
20070162090 Penner Jul 2007 A1
20070179583 Goetzinger et al. Aug 2007 A1
20070191904 Libbus et al. Aug 2007 A1
20070208390 Von Arx et al. Sep 2007 A1
20070247565 Sasiaki et al. Oct 2007 A1
20070250126 Maile et al. Oct 2007 A1
20070274565 Penner Nov 2007 A1
20070282413 Tockman et al. Dec 2007 A1
20070282415 Tockman et al. Dec 2007 A1
20080071178 Greenland et al. Mar 2008 A1
20080071248 Delgado et al. Mar 2008 A1
20080071339 Stalker et al. Mar 2008 A1
20080108904 Heil May 2008 A1
20080176271 Silver et al. Jul 2008 A1
20080275350 Liao et al. Nov 2008 A1
20080283066 Delgado et al. Nov 2008 A1
20090054793 Nunez et al. Feb 2009 A1
20090171274 Harlev et al. Jul 2009 A1
20090270742 Wolinsky et al. Oct 2009 A1
20100016840 Stahmann et al. Jan 2010 A1
Foreign Referenced Citations (33)
Number Date Country
0 897 690 Feb 1999 EP
0 928 598 Aug 2000 EP
1 068 836 Jan 2001 EP
1068836 Jan 2001 EP
1 488 735 Jun 2007 EP
2 333 044 Jul 1999 GB
H11-089942 Apr 1999 JP
2000-507142 Jun 2000 JP
2001-061790 Mar 2001 JP
2006-500991 Jan 2006 JP
WO 8303348 Oct 1983 WO
WO 9934731 Jul 1999 WO
WO 0016686 Mar 2000 WO
WO 0059376 Oct 2000 WO
WO 0167989 Sep 2001 WO
WO 0187137 Nov 2001 WO
WO 2004024034 Mar 2004 WO
WO 2004110263 Dec 2004 WO
WO 2005058202 Jun 2005 WO
WO 2005066849 Jul 2005 WO
WO 2005067817 Jul 2005 WO
WO 2006062725 Jun 2006 WO
WO 2007057739 May 2007 WO
WO 2007062299 May 2007 WO
WO 2007082115 Jul 2007 WO
2008002654 Jan 2008 WO
WO 2008002654 Jan 2008 WO
WO 2008034077 Mar 2008 WO
WO 2008057720 May 2008 WO
WO 2008060197 May 2008 WO
WO 2008144191 Nov 2008 WO
2009006610 Jan 2009 WO
WO 2009006610 Jan 2009 WO
Non-Patent Literature Citations (10)
Entry
Goodall, Eleanor V. et al., “Position-Selective Activation of Peripheral Nerve Fibers with a Cuff Electrode”, IEEE Transactions on Biomedical Engineering, IEEE Service Center, Piscataway, NJ, US, vol. 43, No. 8, Aug. 1, 1996.
International Search Report and Written Opinion issued in PCT/US2010/020756, mailed Sep. 27, 2010.
Invitation to Pay Fees and Partial Search Report issued in PCT/US2010/020756, mailed May 12, 2010.
Goodall, Eleanor V. et al., “Position-Seletive Activation of Peripheral Nerve Fibers with a Cuff Electrode”, IEEE Transactions on Biomedical Engineering, IEEE Service Center, Piscataway, NJ, US, vol. 43, No. 8, Aug. 1, 1996.
Holmes et al. “SirolimusEluting Stents vs. Vascular Brachytherapy for InStent Restenosis Within BareMetal Stents” JAMA295 (11): 1264-1273 Mar. 15, 2006.
Lanning & Shandas, “Development and Validation of Implantable Sensors for Monitoring Function of Prosthetic Heart Valves: In Vitro Studies”, Medical & Biological Engineering & Computing, Jul. 2003, vol. 41, issue 4, pp. 416-424.
Sheth et al. “Subacute Thrombosis and Vascular Injury Resulting From Slotted-Tube Nitinol and Stainless Steel Stents in a Rabbit Carotid Artery Model” Circulation 1996, 94: 1733-1740.
Stone et al. “Paclitaxel-Eluting Stents vs.Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents” JAMA 295(11): 1253-1263, Mar. 15, 2006.
Wenaweser et al. “Stent thrombosis following baremetal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome” European Heart Journal 26: 1180-1187 2005.
International Search Report and Written Opinion from PCT/US2008/062229, mailed Jan. 5, 2009.
Related Publications (1)
Number Date Country
20100210923 A1 Aug 2010 US
Provisional Applications (1)
Number Date Country
61152486 Feb 2009 US